Synopsys stock fell about 2.7% in extended trading on May 27 after the chip-design software company reported fiscal second-quarter results that beat Wall Street’s profit and revenue forecasts but paired the beat with a narrow outlook for the year ahead.
The company said revenue rose 42% from a year earlier to $2.276 billion in fiscal Q2 2026, while non-GAAP earnings came in at $3.35 a share. Analysts had expected adjusted profit of $3.15 to $3.17 a share, so the latest quarter cleared the bar even before the market got to the guidance.
That is the tension in the trade. Investors pushed the stock lower anyway, signaling that the market was looking past the quarterly beat and straight at what Synopsys expects next. For fiscal 2026, the company guided revenue to $9.63 billion to $9.71 billion and non-GAAP EPS to $14.72 to $14.80. The revenue outlook sits only slightly above the analyst consensus of $9.63 billion, leaving little room for disappointment if demand cools later in the year.
Synopsys, which completed its $35 billion acquisition of Ansys in 2024, has been reshaping itself around a broader set of engineering software tools. EDA tools historically made up about two-thirds of total revenue, but analyst commentary has pointed to a sharp shift in recent periods, with design automation revenue surging 96%. The company has said established semiconductor names including NVIDIA, AMD and Intel use its design automation tools, and it has identified Cadence Design Systems and Siemens EDA as key competitors.
That backdrop matters because demand for design automation has been strong in the AI chip-design market, where faster and more complex processors have made software that can model, verify and optimize chips more valuable. Ansys added simulation and verification software to Synopsys’ portfolio, giving the company a broader reach just as customers are spending heavily to bring new chips to market.
The quarter also leaves Synopsys in a familiar position: the business is growing quickly, but the stock is trading on how durable that growth looks from here. Management said its fiscal 2026 revenue midpoint implies roughly 37% growth from fiscal 2025 estimated revenue of $7.0 billion to $7.1 billion, a strong rate by any measure. Still, with shares slipping after the report, investors appeared to decide that the guidance was good rather than great.
For now, the next test is whether Synopsys can turn the Ansys deal and the AI-driven demand cycle into something that keeps revenue climbing without the market demanding an even bigger step up. That is the standard now, and it is why a beat on the quarter was not enough to keep the stock moving higher.
